Financial Insiders - The Latest Buzz in Financial News Online

drug

Gilead Sciences Announced Licensing of Portfolio of HIV Antibodies

Gilead Sciences Announced Licensing of Portfolio of HIV Antibodies

1552 | 0

Gilead Sciences, Inc. (NASDAQ: GILD) announced Thursday that it has licensed The Rockefeller University’s portfolio of broadly neutralizing antibodies (bNAbs) against HIV, including the two clinical-stage agents 3BNC117 and 10-1074. These inve..

Biogen Rises over 35% on Plans to Pursue FDA Approval

Biogen Rises over 35% on Plans to Pursue FDA Approval

663 | 1

Seattle Genetics Shares Soar 15% After Positive Breast Cancer Treatment Trial

Seattle Genetics Shares Soar 15% After Positive Breast Cancer Treatment Trial

1770 | 1

Teva Shares Rise on Opioid Settlement

Teva Shares Rise on Opioid Settlement

1820 | 0

The Latest “Buzz on the Street” Show: Featuring Canopy Growth (NYSE: CGC) (TSX: WEED) Collaboration

The Latest “Buzz on the Street” Show: Featuring Canopy Growth (NYSE: CGC) (TSX: WEED) Collaboration

1241 | 0

Johnson and Johnson Facing Trial For Its Role In The Oklahoma Opioid Crisis

Johnson and Johnson Facing Trial For Its Role In The Oklahoma Opioid Crisis

1366 | 0

Johnson & Johnson Earnings

Johnson & Johnson Earnings

1007 | 0

All rights reserved.

No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).